Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 99,613 shares at $20.27 ($2.0M) on 2026-04-15, disclosed to the SEC on 2026-04-17.
Scheduled sale ($2.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.27 | 81,840 | $1.7M | 81.8% |
| 2 | $20.06 | 6,657 | $134K | 6.6% |
| 3 | $21.10 | 11,116 | $235K | 11.6% |
| Total | $20.35 avg | 99,613 | $2.0M | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |